register

Digital & Innovation

Telstra Health acquires healthcare and hospital software in full

Health Industry Hub | July 4, 2024 |

Strengthening its offering of digital health solutions to hospital providers domestically in Australia and internationally, Telstra Health has acquired the remaining 30% of PowerHealth Solutions, a global leader in healthcare and hospital costing and revenue software solutions.

Since November 2021, Telstra Health has had a majority stake in PowerHealth, a specialist provider in billing, costing and revenue solutions, budgeting, safety and quality, decision support and application integration solutions for hospitals and other healthcare enterprises. Combining Telstra Health and PowerHealth’s portfolio of solutions reflects Telstra Health’s commitment to investing in a sophisticated and comprehensive offering of digital health solutions to an international market.

Established in Adelaide in 1995, PowerHealth has grown to be a global healthcare business with a significant presence in Australia, Canada and the Gulf Cooperation Council (GCC), and operations in Ireland. PowerHealth’s largest customers include the province of Quebec, the Hong Kong Government’s Hospital Authority, the Kingdom of Saudi Arabia Ministry of Health, the Province of Saskatchewan and Government Hospitals in the Kingdom of Bahrain, the New Zealand Government and the majority of Australian hospitals, Local Health Districts or Health and Hospital Services.

Telstra Health’s Hospital Care Executive, Chris Norton, said, “The strategic acquisition of PowerHealth strengthens our offering of solutions, platforms and services to hospital providers, both domestically and internationally. Further investing in PowerHealth is consistent with our domestic and international growth strategy, and further strengthens our solution offerings in hospital care as we continue to focus on and invest in the core markets we support.”

PowerHealth offers six core digital health solutions including PowerPerformance Manager (PPM), a web-based system which calculates hospital delivery costs, integrating private and public funding revenue for providing accurate reports easily and regularly. In 2023 alone, PPM costed 75 per cent of all emergency department, inpatient admission and non-admitted Australian public episodes and AUD$40b of Australian hospital activity.

Enterprise-level patient billing system, Powerbilling and Revenue Collection (PBRC), is another key PowerHealth solution, and in 2023 in Australia PBRC assisted health services to invoice AUD$3.5b in revenue, submit AUD$1.78b electronic claims and raise 8m invoices.

“Collectively with PowerHealth’s suite of solutions now a core component of our offering to hospital providers, we can help to solve some of the biggest challenges facing the health sector both in Australia globally,” added Chris.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.